StockpollyBeta
Get App
Delisting riskPopularity #4,702
BNR · NASDAQ · Medical - Diagnostics & Research

Burning Rock Biotech (ADR) (BNR)

NGS oncology testing, hospital workflows, and biopharma development services.

$15.19
vs last close−1.26 (−7.65%)

Something off on this page? Send us feedback.

13F · 13D/G · Form 4

Institutions164.25%1.74M ADS
17 holders · as of Jun 30, 2026
Adds to164.25%

1.06M ADS as of Aug 25, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing

The share count is from the company's Dec 2022 annual report; nothing newer is on file here.

These groups come from separate filings that can overlap, so they add to 164.25%; nothing is left for Other.

This company has 3 share classes; every stake here is a share of the whole company.

13F · 13D/G · Form 4

HolderStakeSharesDate
Kynam Capital Management, LPInstitution
117.18%1.24M A ADSas of Jun 30, 2026
CRCM LPInstitution
20.06%211,997 A ADSas of Jun 30, 2026
Renaissance Technologies LLCInstitution
5.00%52,838 A ADSas of Jun 30, 2026
Morgan StanleyInstitution
4.12%43,594 A ADSas of Jun 30, 2026
Nikko Asset Management Americas, Inc.Institution
2.81%29,724 A ADSas of Jun 30, 2026
Sumitomo Mitsui Trust Group, Inc.Institution
2.81%29,724 A ADSas of Jun 30, 2026
Bank of America Corp /DE/Institution
2.76%29,164 A ADSas of Jun 30, 2026
Citadel Advisors LLCInstitution
2.58%27,288 A ADSas of Jun 30, 2026
SC China Holding LtdInstitution
2.01%21,212 A ADSas of Jun 30, 2026
UBS Group AGInstitution
1.69%17,916 A ADSas of Jun 30, 2026
Almanack Investment Partners, LLC.Institution
1.53%16,198 A ADSas of Jun 30, 2026
XTX Topco LtdInstitution
1.29%13,621 A ADSas of Jun 30, 2026
BNP Paribas Arbitrage, SNCInstitution
0.26%2,800 A ADSas of Jun 30, 2026
Tower Research Capital LLC (TRC)Institution
0.12%1,242 A ADSas of Jun 30, 2026
JPMorgan Chase & CoInstitution
0.02%166 A ADSas of Jun 30, 2026
Royal Bank of CanadaInstitution
0.01%73 A ADSas of Jun 30, 2026
BlackRock, Inc.Institution
0.00%4 A ADSas of Jun 30, 2026
Crest Top Developments LimitedStrategic
—6.20% of class, as filed—filed Feb 9, 2021
Feng Deng1Insiderdirector
——filed Mar 18, 2026
Yusheng Han2Insiderdirector
——filed Jul 2, 2026
LYFE Capital Management LimitedStrategic
—10.10% of class, as filed—filed Feb 11, 2021
Northern Light Venture Capital III, Ltd. (the “UGP”)Strategic
—13.70% of class, as filed—filed Feb 12, 2021
Licen Lisa Xu1Insiderdirector
——filed Mar 17, 2026
Yi ShiInsider
—5.10% of class, as filed—filed Feb 13, 2024
Zhihong Zhang1Insiderdirector
——filed Mar 17, 2026
  1. The filed share classes (COMMON) could not be matched to the company's, so no percentage.
  2. The filed share classes (COMMON, COMMON) could not be matched to the company's, so no percentage.

13F, as of Jun 30, 2026

17 holders · 1.74M shares · 3 new positions · 9 increased · 4 reduced · 2 closed

HolderShares% of companyChg q/qFiled
Kynam Capital Management, LP1.24M117.18%+11.0KAug 14, 2026
CRCM LP212.0K20.06%−70.1KAug 18, 2026
Renaissance Technologies LLC52.8K5.00%+17.4KAug 13, 2026
Morgan Stanley43.6K4.12%+28.3KAug 13, 2026
Nikko Asset Management Americas, Inc.29.7K2.81%−413Aug 13, 2026
Sumitomo Mitsui Trust Group, Inc.29.7K2.81%−413Jul 30, 2026
Bank of America Corp /DE/29.2K2.76%0Aug 14, 2026
Citadel Advisors LLC27.3K2.58%+9.6KSep 2, 2026

13D/G · 5% or more, as filed

Holder% of classSharesFormFiled
Kynam Capital Management, LP13.97%013GMay 15, 2026

Form 4

Latest trades

DateInsiderTypeSharesAvg priceOwned after
Jun 11, 2026
Yusheng Handirector
Purchase24,760$8.7417,697,436
Jun 12, 2026
Yusheng Handirector
Purchase210,000$9.2517,907,436
Jun 16, 2026
Yusheng Handirector
Purchase111,110$9.0018,018,546
Jun 22, 2026
Yusheng Handirector
Purchase104,650$7.4518,123,196
Jun 23, 2026
Yusheng Handirector
Purchase5,990$7.5018,129,186
Jun 24, 2026
Yusheng Handirector
Purchase250,000$8.0018,379,186
Jun 26, 2026
Yusheng Handirector
Purchase24,900$8.0018,404,086
Mar 31, 2026
Yusheng Handirector
Purchase314,870$17.3617,672,676

House and Senate disclosures

Not reported.